Fierro, Maria T <br/><br/>
Systemic therapy with cyclophosphamide and anti-CD20 antibody (rituximab) in relapsed primary cutaneous B-cell lymphoma: a report of 7 cases.  [electronic resource] 

 -  Journal of the American Academy of Dermatology  Aug 2003 
 - 281-7 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>0190-9622 
<br/><br/><label>Standard No.: </label>10.1067/s0190-9622(03)00855-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antigens, CD20--metabolism<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Agents, Alkylating--therapeutic use<br/>Cyclophosphamide--therapeutic use<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Flow Cytometry<br/>Humans<br/>Lymphoma, B-Cell--drug therapy<br/>Male<br/>Middle Aged<br/>Recurrence<br/>Rituximab<br/>Skin Neoplasms--drug therapy